Preliminary results from methylation studies performed by our group indicate that the expression of POU4F2 increases in NB cell lines treated with a demethylating agent in conjunction with a histone deacetylase inhibitor (Carén et al, manuscript in preparation). This evidence concerns the gene POU4F2 and neuroblastoma.